martes, 21 de mayo de 2024

FDA approves first interchangeable biosimilars to Eylea to treat macular degeneration and other eye conditions

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-interchangeable-biosimilars-eylea-treat-macular-degeneration-and-other-eye

No hay comentarios: